Session Details

Session Details

01:30 PM - 01:45 PM - Ballroom 4

Hui Yang - HuidaGene Therapeutics Co., Ltd.

261: Multi-Step Engineered Adeno-Associated Virus Enables Whole-Brain mRNA Delivery

01:30 PM - 03:15 PM - Ballroom 4

Victoria Madigan - PhD - MIT

Co-Chair

01:30 PM - 03:15 PM - Ballroom 4

Miguel Chuapoco -

Co-Chair

01:45 PM - 02:00 PM - Ballroom 4

Ryan Hsu - BS - Salk Institute & UC San Diego

262: Optimization of RNA End Joining (REJ) to Safely and Efficiently Express Large Proteins

02:00 PM - 02:15 PM - Ballroom 4

Arun Srivastava - PhD - University of Florida College of Medicine

263: Encapsidation of, and Transgene Expression from, Generation Z (Genz) Single-Stranded AAV Vectors is AAV Serotype Capsid-Specific

02:15 PM - 02:30 PM - Ballroom 4

Jakob Shoti - University of Florida

264: Development of ITR-Modified AAVrh74 Vectors with Improved Transgene Expression in Primary Human Skeletal Muscle Cells In Vitro and in Murine Skeletal Muscles In Vivo

02:30 PM - 02:45 PM - Ballroom 4

Gerard Coughlin - California Institute of Technology

265: Transcriptional Crosstalk Between AAV Genomes Depends on Concatemer Formation and Enables Cell Type-Targeted Delivery of Oversized Cargo

02:45 PM - 03:00 PM - Ballroom 4

Seongmin Jang - PhD - Caltech

266: Newly Identified AAV Binders: Blood-Brain-Barrier Transcytosis Mediator LRP6 for Engineered AAVs and Immune Cytokine IL3 for AAV9-Host Interaction

03:00 PM - 03:15 PM - Ballroom 4

Leah Whitfield - University of North Carolina at Chapel Hill

267: Creation of an AAV-Based Replication Origin for Novel AAV Vectors That Cannot Be Replicated in Nature